Delays in fibrosis staging reduce the likelihood of achieving hepatitis C treatment and cure.
Austin T JonesLisa Moreno-WaltonSierra D SossamonFnu TahmeenaTorrence TranChristopher BrionesRachael StevensKatherine IsaacsonHua HeStacey RhodesJeffrey PercakPatricia J KissingerPublished in: Infectious diseases (London, England) (2023)
Delays in hepatitis fibrosis staging were significantly associated with decreased likelihood of HCV treatment initiation and SVR.